Social functioning and the depressed patient

International Journal of Psychiatry in Clinical Practice

Volumn 3, Issue SUPPL. 1, 1999, Pages

  Paykel, Eugene ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Depression; Reboxetine; Selective noradrenaline re uptake inhibitor; Social adaptation self evaluation scale (SASS); Social functioning

Indexed keywords

FLUOXETINE; REBOXETINE;

CLINICAL FEATURE; CONFERENCE PAPER; DEPRESSION; HUMAN; MOTIVATION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SELF CONCEPT; SELF EVALUATION; SOCIAL ADAPTATION; SOCIAL INTERACTION;

EID: 0032939306     PISSN: 13651501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Hamilton M (1960) A rating scale for depression. J Neurosurg Psychiatry 23: 56-62.
2. Montgomery SA, Åsberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382-9.
3. Guy A (1976) ECDEU Assessment Manual for Psychopharmacology. US Department of Health, Education and Welfare, Public Health Service, Alcohol, Drug Abuse and Mental Health Administration: Rockville, MD.
4. Bosc M, Dubini A, Polin V (1997) Development and validation of a social functioning scale, the Social Adaptation Self-evaluation Scale. Eur Neuropsychopharmacol 7: S57-S70.
5. Montgomery SA (1997) Reboxetine: additional benefits to the depressed patient. J Psychopharmacol 11: S9-S15.
6. Dubini A, Bosc M, Polin V (1997) Noradrenaline-selective versus serotonin-selective antidepressant therapy: differential effects on social functioning. J Psychopharmacol 11: S17-S23.
7. Massana J, Mōller HJ, Burrows GD, Montenegro RM (1999) Reboxetine: a double blind comparison with fluoxetine in major depressive disorder. Int Clin Psychopharmacol In press.
8. Carlsson A, Corrodi H, Fuxe K et al (1969) Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-α-ethyl-metatyramine. Eur J Pharmacol 5: 357-66.
9. Maas JW (1975) Biogenic amines and depression. Arch Gen Psychiatry 32: 1357-61.
10. Dubini A, Bosc M, Polin V (1997) Do noradrenaline and serotonin differentially affect social motivation and behaviour? Eur Neuropsychopharmacol 7: S49-S55.
11. Task Force of the CINP (1993) Impact of neuropharmacology in the 1990s - strategies for the therapy of depressive illness. Eur Neuropsychopharmacol 3: 153-6.
12. Altamura AC, Percudani M (1993) The use of antidepressants for long-term treatment of recurrent depression: rationale, current methodologies, and future directions. J Clin Psychiatry 54: 29-37.
13. Frank E, Kupfer DJ, Perel JM et al (1993) Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression. J Affect Disord 27: 139-45.
14. Thase ME (1992) Long-term treatments of recurrent depressive disorders. J Clin Psychiatry 53: 32-41.